Clinical Trials and Therapeutics
Use of antisense oligonucleotide in Progressive supranuclear palsy

 Theme Group:


Phase 1 clinical trial funded by Novartis

About the project:

Phase 1 first in human clinical trial in patients with progressive supranuclear palsy.

Read more

Key iDeAC expertise:

Dr Boyd Ghosh

Clinical Trials

Related projects: